|8-KFeb 18, 4:23 PM ET

INTEGRATED BIOPHARMA INC 8-K

Research Summary

AI-generated summary

Updated

Integrated Biopharma Files Lease Amendment (8-K)

What Happened
Integrated Biopharma, Inc. (INBP) filed a Form 8‑K on February 18, 2026 under Item 9.01 to furnish an exhibit: a Fourth Amendment of Lease dated February 17, 2026 between Vitamin Realty Associates, L.L.C. and Manhattan Drug Company, Inc. The company attached the amendment as Exhibit 10.1 and included the Cover Page Interactive Data File (Inline XBRL) as Exhibit 104.

Key Details

  • Filing date: February 18, 2026 (Form 8‑K).
  • Exhibit 10.1: Fourth Amendment of Lease, dated February 17, 2026.
  • Counterparties named in the amendment: Vitamin Realty Associates, L.L.C. and Manhattan Drug Company, Inc.
  • Exhibit 104: Cover Page Interactive Data File (Inline XBRL) included.

Why It Matters
This filing provides investors with the actual lease amendment document for review. Lease amendments can change a company’s occupancy commitments, rent obligations, or other material contract terms—so shareholders and creditors should review Exhibit 10.1 to see any specific changes. The 8‑K itself is a disclosure filing and does not report other events such as earnings or executive changes.